eISSN: 2450-4459
ISSN: 2450-3517
Lekarz POZ
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
1/2019
vol. 5
 
Share:
Share:
more
 
 
abstract:
Review paper

The role of single-pill combination therapy in light of the latest ESC/ESH 2018 guidelines for the management of arterial hypertension, with particular emphasis on preparations containing valsartan

Marcin Barylski

Online publish date: 2019/03/20
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Single-pill combination therapy is the future of antihypertensive treatment. Doctors have more and more practical experience in their use and are witnessing the implementation of new, complex preparations appearing on the pharmaceutical market, which improve cooperation with the patient, facilitate treatment, and gradually increase the proportion of people with properly controlled blood pressure. The present paper discusses the role of a single-pill combination of two (valsartan and amlodipine) or three (valsartan, amlodipine, and hydrochlorothiazide) antihypertensive drugs, in light of the latest ESC/ESH 2018 guidelines.
keywords:

single-pill combination, guidelines, valsartan, amlodipine, hydrochlorothiazide

Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe